12 results
6-K
EX-99.1
CNTB
Connect Biopharma Holdings Ltd
21 Nov 23
Exclusive License and Collaboration Agreement
6:13am
and stability testing, process and packaging development and improvement, process validation, process scale-up, formulation development, delivery system … , formulation, mean of delivery or dosage, use, or methods of use or packaging of such Licensed Compound or Licensed Product, any discovery or Development
20-F
2021 FY
CNTB
Connect Biopharma Holdings Ltd
31 Mar 22
Annual report (foreign)
4:33pm
is subject to comprehensive government regulation and supervision encompassing the approval, registration, manufacturing, packaging, licensing … , if the FDA, the NMPA or foreign regulatory authorities approve our product candidates, the manufacturing processes, labeling, packaging
424B4
CNTB
Connect Biopharma Holdings Ltd
19 Mar 21
Prospectus supplement with pricing info
4:49pm
, the NMPA or foreign regulatory authorities approve our product candidates, the manufacturing processes, labeling, packaging, distribution, adverse … to comprehensive government regulation and supervision encompassing the approval, registration, manufacturing, packaging, licensing and marketing of new
F-1/A
tk86rc8s
18 Mar 21
Registration statement (foreign) (amended)
6:15am
F-1/A
bnn7wseq5msu67axh
12 Mar 21
Registration statement (foreign) (amended)
5:02pm
F-1
ct8gixsq
26 Feb 21
Registration statement (foreign)
4:56pm
F-1
EX-10.5
j4410pde7qa88m
26 Feb 21
Registration statement (foreign)
4:56pm
DRS/A
EX-10.5
45o6jo 5ay
26 Jan 21
Draft registration statement (amended)
12:00am
DRS/A
mcrx6472q1gb40428a
26 Jan 21
Draft registration statement (amended)
12:00am
DRS
g765x zejhef2z2zne5w
17 Dec 20
Draft registration statement
12:00am
- Prev
- 1
- Next